Cost analysis of oral antidepressant drugs available in India
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2015, Vol 5, Issue 5
Abstract
Background: Depression is a disorder that disrupts the public health through factors such as its occurrence, distress, ill health, and economic burden. There is a wide variation in the prices of antidepressant drugs marketed in India. Aims and Objective: To find out the price variations in the oral antidepressant drugs available in India either as a single drug or in combination and to evaluate the differences in the cost of various brands of the same oral antidepressant drug by calculating the percentage variation in cost in Indian rupees. Materials and Methods: The cost of a particular drug being manufactured by different companies, in the same strength and dosage forms, was obtained from ‘‘Current Index of Medical Specialties’’ July–October, 2014, and ‘‘Indian Drug Review, 2014;21(4)’’. The difference between the maximum and minimum prices of the same drug and the percentage variation in the prices was calculated. Result: The prices of a total of 25 drugs (21 single and 4 combination preparations) available in 66 different formulations were analyzed. In single drug therapy, among tricyclic antidepressants, reboxetine (2 mg) showed the maximum price variation of 900%. In atypical antidepressants, bupropion hydrochloride (150 mg) showed the maximum price variation of 447.94%. In selective serotonin reuptake inhibitors (SSRIs), paroxetine (37.5 mg) showed the maximum price variation of 1116.66%. In serotonin norepinephrine reuptake inhibitors (SNRIs), Venlafaxine hydrochloride (37.5 mg) showed the maximum price variation of 246.15%. In monoamine oxidase (MAO)-A inhibitors, moclobemide (150 mg) showed the maximum price variation of 246.15%. In combination therapies, chlordiazepoxide with amitriptyline showed the maximum price variation of 227.23%. Conclusion: The average percentage variations of different brands of the same drug manufactured in India is very wide. The management of the marketing drugs should be directed toward maximizing the therapeutic benefits to the community and minimizing the economic burden.
Authors and Affiliations
Abhinay P Paunikar, Kiran A Bhave
Keywords
Related Articles
- EP ID EP118004
- DOI 10.5455/njppp.2015.5.1105201556
- Views 121
- Downloads 0
Dapsone hypersensitivity syndrome - A case report
Dapsone is widely used for the treatment of leprosy and other immunological and inflammatory dermatological conditions such as dermatitis herpetiformis, vesiculobullous dermatoses, and pustular psoriasis. Dapsone hyperse...
Awareness, knowledge, and perception among pharmacists on the National Health Insurance Program in Indonesia
Background: The Indonesian government is promoting health in the community by a program called Indonesia National Health Insurance (NHI) or Jaminan Kesehatan Nasional which is held by the government board. Pharmacists ha...
Effect of filgrastim (recombinant human granulocyte colony stimulating factor) on spatial memory in aged rats
Background: Apart from functioning as a multimodal hematopoietic growth factor, granulocyte colony-stimulating factor (G-CSF) causes intense consequences on the brain. It has been viewed that G-CSF boosts the impr...
The influence of carrageenan on markers of endogenous intoxication in rats
Background: The growth of the world population and the need to increase food production led to the widespread use of food additives. One of such additives is carrageenan. Potentially negative health effects of carrageena...
Impact of simulation-based teaching of applied physiology of the cardiovascular system on the undergraduate medical student
Background: The undergraduate medical student, in his I year of studies, is required to know about Applied Physiology. The teaching of Applied Physiology concepts that occur in real life situations in a classroom is unde...